| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.001 | 0.917 | 5 Hydroxytryptamine release stimulant | 0.854 0.003 CID_15366337 0.877 0.002 CID_73707588 | ||
| 0.7 | 0.004 | 0.7 | 5 Hydroxytryptamine 1 agonist | 0.44 0.005 CID_15366337 0.124 0.017 CID_73707588 | ||
| 0.629 | 0.004 | 0.629 | 5 Hydroxytryptamine agonist | 0.322 0.007 CID_15366337 0.102 0.033 CID_73707588 | ||
| 0.628 | 0.004 | 0.629 | Peroxidase inhibitor | 0.629 0.004 CID_15366337 | CID_15366337 | |
| 0.609 | 0.002 | 0.609 | Phenylalanine 4-hydroxylase inhibitor | 0.299 0.004 CID_15366337 0.126 0.017 CID_73707588 | ||
| 0.597 | 0.003 | 0.597 | 5 Hydroxytryptamine 1E antagonist | 0.401 0.005 CID_15366337 | ||
| 0.581 | 0.01 | 0.615 | GABA C receptor rho-3 antagonist | 0.615 0.006 CID_15366337 | CID_15366337 | |
| 0.567 | 0.003 | 0.567 | 5 Hydroxytryptamine 1B agonist | 0.179 0.004 CID_15366337 0.113 0.005 CID_73707588 | ||
| 0.573 | 0.014 | 0.573 | Interleukin antagonist | 0.565 0.014 CID_15366337 0.368 0.036 CID_73707588 | ||
| 0.591 | 0.037 | 0.774 | Caspase 9 stimulant | 0.774 0.015 CID_15366337 0.554 0.044 CID_73707588 | CID_15366337 | |
| 0.54 | 0.002 | 0.54 | Myeloperoxidase inhibitor | 0.271 0.004 CID_15366337 0.079 0.068 CID_73707588 | ||
| 0.519 | 0.009 | 0.528 | Psychostimulant | 0.398 0.023 CID_15366337 0.528 0.009 CID_73707588 | CID_73707588 | |
| 0.521 | 0.02 | 0.54 | Calcium channel L-type activator | 0.54 0.015 CID_15366337 0.358 0.111 CID_73707588 | CID_15366337 | |
| 0.469 | 0.002 | 0.469 | 5 Hydroxytryptamine 2A agonist | 0.256 0.004 CID_15366337 | ||
| 0.487 | 0.043 | 0.493 | 15-Lipoxygenase inhibitor | 0.493 0.042 CID_15366337 | CID_15366337 | |
| 0.439 | 0.002 | 0.439 | Histamine N-methyltransferase inhibitor | 0.193 0.006 CID_15366337 0.135 0.021 CID_73707588 | ||
| 0.438 | 0.002 | 0.438 | 5 Hydroxytryptamine 3E antagonist | 0.328 0.004 CID_15366337 0.193 0.076 CID_73707588 | ||
| 0.413 | 0.002 | 0.413 | 5 Hydroxytryptamine 3A agonist | 0.295 0.004 CID_15366337 | ||
| 0.42 | 0.019 | 0.42 | Insulysin inhibitor | 0.391 0.024 CID_15366337 | ||
| 0.413 | 0.015 | 0.413 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.226 0.064 CID_15366337 | ||
| 0.393 | 0.009 | 0.397 | Tyrosine 3 hydroxylase inhibitor | 0.397 0.008 CID_15366337 | CID_15366337 | |
| 0.386 | 0.005 | 0.386 | GABA C receptor agonist | 0.184 0.024 CID_15366337 0.099 0.068 CID_73707588 | ||
| 0.445 | 0.064 | 0.494 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.494 0.036 CID_15366337 | CID_15366337 | |
| 0.379 | 0.003 | 0.379 | 5 Hydroxytryptamine 5A antagonist | 0.106 0.014 CID_15366337 | ||
| 0.417 | 0.045 | 0.61 | Aldehyde oxidase inhibitor | 0.61 0.018 CID_15366337 | CID_15366337 | |
| 0.399 | 0.027 | 0.399 | Superoxide dismutase inhibitor | 0.335 0.04 CID_15366337 | ||
| 0.362 | 0.009 | 0.362 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.17 0.056 CID_15366337 | ||
| 0.384 | 0.032 | 0.414 | DNA damaging | 0.28 0.066 CID_15366337 0.414 0.026 CID_73707588 | CID_73707588 | |
| 0.35 | 0.004 | 0.35 | 5 Hydroxytryptamine 1D antagonist | 0.166 0.01 CID_15366337 | ||
| 0.371 | 0.03 | 0.371 | Amyloid beta aggregation inhibitor | 0.358 0.032 CID_15366337 0.233 0.063 CID_73707588 | ||
| 0.345 | 0.005 | 0.345 | Histidine decarboxylase inhibitor | 0.182 0.015 CID_15366337 | ||
| 0.344 | 0.004 | 0.344 | 5 Hydroxytryptamine 5 antagonist | 0.118 0.012 CID_15366337 | ||
| 0.343 | 0.005 | 0.343 | Nitric-oxide synthase stimulant | 0.34 0.005 CID_15366337 0.342 0.005 CID_73707588 | ||
| 0.405 | 0.073 | 0.507 | Histamine release inhibitor | 0.507 0.026 CID_15366337 0.505 0.027 CID_73707588 | CID_15366337 | |
| 0.35 | 0.023 | 0.35 | Growth hormone agonist | 0.269 0.039 CID_15366337 0.157 0.082 CID_73707588 | ||
| 0.363 | 0.042 | 0.363 | Calcium channel activator | 0.351 0.049 CID_15366337 | ||
| 0.318 | 0.003 | 0.318 | Prolactin inhibitor | 0.306 0.003 CID_15366337 | ||
| 0.341 | 0.04 | 0.341 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.302 0.062 CID_15366337 | ||
| 0.3 | 0.004 | 0.307 | GABA C receptor antagonist | 0.307 0.004 CID_15366337 | CID_15366337 | |
| 0.317 | 0.023 | 0.459 | DNA methylase inhibitor | 0.332 0.02 CID_15366337 0.459 0.007 CID_73707588 | CID_73707588 | |
| 0.333 | 0.043 | 0.535 | Free radical scavenger | 0.342 0.041 CID_15366337 0.535 0.013 CID_73707588 | CID_73707588 | |
| 0.302 | 0.013 | 0.302 | Adenylate cyclase inhibitor | 0.223 0.022 CID_15366337 0.2 0.025 CID_73707588 | ||
| 0.287 | 0.007 | 0.287 | NMDA receptor antagonist | 0.167 0.02 CID_15366337 | ||
| 0.281 | 0.003 | 0.281 | Adenylate cyclase stimulant | 0.209 0.01 CID_15366337 0.204 0.012 CID_73707588 | ||
| 0.292 | 0.015 | 0.292 | Neurotensin receptor agonist | 0.276 0.017 CID_15366337 0.149 0.104 CID_73707588 | ||
| 0.312 | 0.035 | 0.312 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.228 0.072 CID_15366337 | ||
| 0.373 | 0.097 | 0.444 | 5 Hydroxytryptamine release inhibitor | 0.423 0.065 CID_15366337 0.444 0.054 CID_73707588 | CID_73707588 | |
| 0.328 | 0.053 | 0.426 | Aryl hydrocarbon receptor agonist | 0.426 0.033 CID_15366337 | CID_15366337 | |
| 0.279 | 0.004 | 0.331 | CF transmembrane conductance regulator agonist | 0.331 0.004 CID_15366337 0.208 0.017 CID_73707588 | CID_15366337 | |
| 0.288 | 0.014 | 0.288 | NADPH oxidase inhibitor | 0.265 0.018 CID_15366337 0.217 0.029 CID_73707588 | ||
| 0.292 | 0.023 | 0.351 | Lipocortins synthesis antagonist | 0.351 0.013 CID_15366337 0.244 0.035 CID_73707588 | CID_15366337 | |
| 0.27 | 0.003 | 0.27 | GABA B receptor agonist | 0.17 0.004 CID_15366337 0.071 0.064 CID_73707588 | ||
| 0.27 | 0.004 | 0.292 | GABA C receptor rho-1 antagonist | 0.292 0.004 CID_15366337 | CID_15366337 | |
| 0.27 | 0.005 | 0.27 | 5 Hydroxytryptamine 1B antagonist | 0.162 0.011 CID_15366337 | ||
| 0.27 | 0.008 | 0.46 | GABA C receptor rho-2 antagonist | 0.46 0.003 CID_15366337 | CID_15366337 | |
| 0.262 | 0.003 | 0.262 | 5 Hydroxytryptamine 7 agonist | 0.107 0.006 CID_15366337 | ||
| 0.265 | 0.007 | 0.265 | Toll-Like receptor 2 antagonist | 0.25 0.009 CID_15366337 0.135 0.064 CID_73707588 | ||
| 0.264 | 0.007 | 0.264 | Protein kinase C zeta inhibitor | 0.198 0.011 CID_15366337 | ||
| 0.261 | 0.007 | 0.261 | 5 Hydroxytryptamine 1F antagonist | 0.195 0.01 CID_15366337 | ||
| 0.258 | 0.006 | 0.258 | Protein kinase C gamma inhibitor | 0.198 0.014 CID_15366337 0.108 0.065 CID_73707588 | ||
| 0.264 | 0.013 | 0.264 | Alpha 2b adrenoreceptor antagonist | 0.214 0.021 CID_15366337 | ||
| 0.294 | 0.048 | 0.297 | 5 Hydroxytryptamine uptake stimulant | 0.297 0.046 CID_15366337 | CID_15366337 | |
| 0.274 | 0.036 | 0.367 | DNA methyltransferase I inhibitor | 0.337 0.016 CID_15366337 0.367 0.012 CID_73707588 | CID_73707588 | |
| 0.242 | 0.005 | 0.242 | Adrenaline agonist | 0.185 0.008 CID_15366337 | ||
| 0.34 | 0.108 | 0.662 | Antibacterial | 0.303 0.133 CID_15366337 0.662 0.012 CID_73707588 | CID_73707588 | |
| 0.318 | 0.086 | 0.655 | Transcription factor NF kappa B inhibitor | 0.303 0.092 CID_15366337 0.655 0.025 CID_73707588 | CID_73707588 | |
| 0.241 | 0.013 | 0.241 | 5 Hydroxytryptamine 2C antagonist | 0.113 0.039 CID_15366337 | ||
| 0.283 | 0.058 | 0.382 | Antiamyloidogenic | 0.315 0.047 CID_15366337 0.382 0.032 CID_73707588 | CID_73707588 | |
| 0.226 | 0.004 | 0.24 | DOPA decarboxylase inhibitor | 0.24 0.004 CID_15366337 | CID_15366337 | |
| 0.233 | 0.014 | 0.233 | 5 Hydroxytryptamine 1 antagonist | 0.1 0.037 CID_15366337 | ||
| 0.233 | 0.014 | 0.233 | Carbonic anhydrase XV inhibitor | 0.105 0.06 CID_15366337 | ||
| 0.221 | 0.004 | 0.221 | 5 Hydroxytryptamine 3 agonist | 0.109 0.012 CID_15366337 | ||
| 0.259 | 0.043 | 0.259 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.205 0.062 CID_15366337 | ||
| 0.235 | 0.021 | 0.235 | 5 Hydroxytryptamine 2B antagonist | 0.148 0.042 CID_15366337 | ||
| 0.216 | 0.006 | 0.216 | CYP2A6 inhibitor | 0.152 0.016 CID_15366337 | ||
| 0.305 | 0.094 | 0.482 | Vasodilator, peripheral | 0.482 0.032 CID_15366337 0.281 0.107 CID_73707588 | CID_15366337 | |
| 0.217 | 0.008 | 0.217 | NMDA 2 receptor antagonist | 0.18 0.011 CID_15366337 | ||
| 0.27 | 0.061 | 0.693 | Angiogenesis stimulant | 0.223 0.083 CID_15366337 0.693 0.005 CID_73707588 | CID_73707588 | |
| 0.279 | 0.07 | 0.562 | Antioxidant | 0.304 0.06 CID_15366337 0.562 0.014 CID_73707588 | CID_73707588 | |
| 0.21 | 0.003 | 0.21 | 5 Hydroxytryptamine 1D agonist | 0.074 0.005 CID_15366337 | ||
| 0.288 | 0.082 | 0.428 | Interleukin 2 agonist | 0.235 0.136 CID_15366337 0.428 0.02 CID_73707588 | CID_73707588 | |
| 0.217 | 0.011 | 0.217 | Carbonic anhydrase VI inhibitor | 0.111 0.033 CID_15366337 0.091 0.046 CID_73707588 | ||
| 0.254 | 0.05 | 0.254 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.184 0.09 CID_15366337 | ||
| 0.286 | 0.083 | 0.559 | Immunostimulant | 0.213 0.113 CID_15366337 0.559 0.022 CID_73707588 | CID_73707588 | |
| 0.229 | 0.028 | 0.229 | 5 Hydroxytryptamine antagonist | 0.104 0.075 CID_15366337 | ||
| 0.245 | 0.045 | 0.245 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.184 0.087 CID_15366337 0.174 0.101 CID_73707588 | ||
| 0.277 | 0.08 | 0.385 | Spasmolytic | 0.207 0.114 CID_15366337 0.385 0.043 CID_73707588 | CID_73707588 | |
| 0.202 | 0.012 | 0.202 | Porphobilinogen synthase inhibitor | 0.166 0.017 CID_15366337 | ||
| 0.214 | 0.026 | 0.214 | Death-associated protein kinase 2 inhibitor | 0.19 0.043 CID_15366337 | ||
| 0.2 | 0.016 | 0.2 | Carbonic anhydrase III inhibitor | 0.138 0.033 CID_15366337 0.107 0.055 CID_73707588 | ||
| 0.191 | 0.007 | 0.191 | Somatostatin 1 agonist | 0.158 0.012 CID_15366337 0.115 0.026 CID_73707588 | ||
| 0.187 | 0.004 | 0.187 | 5 Hydroxytryptamine 2 agonist | 0.092 0.011 CID_15366337 | ||
| 0.184 | 0.005 | 0.184 | NMDA 2A receptor antagonist | 0.152 0.007 CID_15366337 | ||
| 0.214 | 0.036 | 0.387 | Melanin inhibitor | 0.323 0.019 CID_15366337 0.387 0.013 CID_73707588 | CID_73707588 | |
| 0.202 | 0.03 | 0.202 | 5 Hydroxytryptamine 2 antagonist | 0.1 0.072 CID_15366337 | ||
| 0.188 | 0.016 | 0.188 | 5 Hydroxytryptamine 1A antagonist | 0.085 0.038 CID_15366337 | ||
| 0.233 | 0.064 | 0.387 | Peptidyltransferase inhibitor | 0.387 0.008 CID_73707588 | CID_73707588 | |
| 0.171 | 0.002 | 0.171 | Dopamine D5 agonist | 0.083 0.005 CID_15366337 | ||
| 0.237 | 0.069 | 0.237 | Neuropeptide Y2 antagonist | 0.21 0.103 CID_15366337 | ||
| 0.188 | 0.02 | 0.188 | Alpha 2c adrenoreceptor antagonist | 0.165 0.026 CID_15366337 | ||
| 0.172 | 0.005 | 0.172 | Somatostatin agonist | 0.091 0.008 CID_15366337 | ||
| 0.205 | 0.039 | 0.205 | MAO inhibitor | 0.108 0.083 CID_15366337 | ||
| 0.205 | 0.041 | 0.205 | Phospholipase C inhibitor | 0.189 0.052 CID_15366337 0.174 0.068 CID_73707588 | ||
| 0.182 | 0.018 | 0.208 | Interleukin 8 antagonist | 0.208 0.011 CID_15366337 | CID_15366337 | |
| 0.21 | 0.047 | 0.21 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.199 0.051 CID_15366337 | ||
| 0.18 | 0.017 | 0.18 | Alpha 2a adrenoreceptor antagonist | 0.096 0.038 CID_15366337 | ||
| 0.184 | 0.023 | 0.184 | Nav1.4 sodium channel blocker | 0.151 0.033 CID_15366337 0.094 0.086 CID_73707588 | ||
| 0.187 | 0.031 | 0.21 | Aldehyde dehydrogenase inhibitor | 0.21 0.025 CID_15366337 0.156 0.044 CID_73707588 | CID_15366337 | |
| 0.224 | 0.069 | 0.393 | Pyruvate kinase inhibitor | 0.393 0.022 CID_15366337 | CID_15366337 | |
| 0.218 | 0.063 | 0.218 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.192 0.082 CID_15366337 | ||
| 0.171 | 0.017 | 0.19 | Creatine kinase inhibitor | 0.19 0.012 CID_15366337 | CID_15366337 | |
| 0.173 | 0.02 | 0.179 | Adenylate kinase inhibitor | 0.179 0.018 CID_15366337 0.14 0.031 CID_73707588 | CID_15366337 | |
| 0.165 | 0.014 | 0.165 | Alpha adrenoreceptor agonist | 0.127 0.02 CID_15366337 | ||
| 0.166 | 0.015 | 0.166 | Protein kinase C delta inhibitor | 0.15 0.021 CID_15366337 | ||
| 0.169 | 0.018 | 0.18 | Heat shock protein 70 antagonist | 0.18 0.012 CID_15366337 0.175 0.014 CID_73707588 | CID_15366337 | |
| 0.185 | 0.036 | 0.185 | Toll-Like receptor antagonist | 0.139 0.064 CID_15366337 | ||
| 0.161 | 0.014 | 0.161 | Dopamine agonist | 0.094 0.03 CID_15366337 | ||
| 0.156 | 0.012 | 0.156 | Glutamate decarboxylase inhibitor | 0.079 0.045 CID_15366337 | ||
| 0.149 | 0.006 | 0.168 | Beta 3 adrenoreceptor antagonist | 0.168 0.005 CID_15366337 | CID_15366337 | |
| 0.158 | 0.017 | 0.158 | Aminoacyl-tRNA synthetase inhibitor | 0.1 0.045 CID_15366337 0.115 0.033 CID_73707588 | ||
| 0.159 | 0.019 | 0.159 | Nitric-oxide synthase inhibitor | 0.092 0.074 CID_15366337 | ||
| 0.17 | 0.033 | 0.176 | MAP kinase kinase 4 inhibitor | 0.176 0.028 CID_15366337 | CID_15366337 | |
| 0.177 | 0.041 | 0.177 | M18 aspartyl aminopeptidase inhibitor | 0.116 0.074 CID_15366337 | ||
| 0.256 | 0.122 | 0.429 | Apoptosis antagonist | 0.25 0.128 CID_15366337 0.429 0.031 CID_73707588 | CID_73707588 | |
| 0.183 | 0.049 | 0.34 | Protein kinase stimulant | 0.15 0.068 CID_15366337 0.34 0.013 CID_73707588 | CID_73707588 | |
| 0.145 | 0.011 | 0.145 | 5 Hydroxytryptamine 1A agonist | 0.094 0.017 CID_15366337 | ||
| 0.164 | 0.03 | 0.164 | Falcipain 3 inhibitor | 0.158 0.033 CID_15366337 | ||
| 0.162 | 0.03 | 0.162 | GABA receptor agonist | 0.161 0.03 CID_15366337 | ||
| 0.155 | 0.023 | 0.172 | HIV-1 integrase (Overall Integration) inhibitor | 0.172 0.018 CID_15366337 | CID_15366337 | |
| 0.194 | 0.063 | 0.217 | Sigma receptor agonist | 0.217 0.056 CID_15366337 | CID_15366337 | |
| 0.142 | 0.011 | 0.142 | Alcohol oxidase inhibitor | 0.115 0.015 CID_15366337 | ||
| 0.258 | 0.127 | 0.428 | Vasodilator, coronary | 0.263 0.122 CID_15366337 0.428 0.028 CID_73707588 | CID_73707588 | |
| 0.182 | 0.051 | 0.182 | Acetylcholine M1 receptor antagonist | |||
| 0.155 | 0.027 | 0.155 | 5 Hydroxytryptamine 2A antagonist | 0.073 0.065 CID_15366337 | ||
| 0.174 | 0.046 | 0.504 | Hemostatic | 0.504 0.004 CID_73707588 | CID_73707588 | |
| 0.194 | 0.066 | 0.194 | LIM domain kinase 1 inhibitor | 0.192 0.067 CID_15366337 | ||
| 0.161 | 0.033 | 0.161 | Aminopeptidase B inhibitor | 0.127 0.049 CID_15366337 | ||
| 0.15 | 0.025 | 0.423 | Beta glucuronidase inhibitor | 0.223 0.01 CID_15366337 0.423 0.004 CID_73707588 | CID_73707588 | |
| 0.21 | 0.086 | 0.346 | RNA-directed DNA polymerase inhibitor | 0.346 0.024 CID_15366337 0.175 0.142 CID_73707588 | CID_15366337 | |
| 0.184 | 0.06 | 0.35 | Thrombolytic | 0.135 0.094 CID_15366337 0.35 0.017 CID_73707588 | CID_73707588 | |
| 0.169 | 0.047 | 0.169 | Histone deacetylase SIRT1 inhibitor | 0.11 0.104 CID_15366337 | ||
| 0.151 | 0.03 | 0.225 | Photosensitizer | 0.225 0.009 CID_15366337 0.224 0.009 CID_73707588 | CID_15366337 | |
| 0.149 | 0.027 | 0.149 | Alpha 2 adrenoreceptor antagonist | 0.097 0.05 CID_15366337 | ||
| 0.157 | 0.039 | 0.253 | Topoisomerase I inhibitor | 0.214 0.023 CID_15366337 0.253 0.016 CID_73707588 | CID_73707588 | |
| 0.175 | 0.057 | 0.205 | Phospholipase A2 inhibitor | 0.205 0.04 CID_15366337 0.148 0.076 CID_73707588 | CID_15366337 | |
| 0.127 | 0.009 | 0.127 | Beta adrenoreceptor antagonist | 0.113 0.012 CID_15366337 | ||
| 0.175 | 0.058 | 0.175 | Protein kinase C nu inhibitor | |||
| 0.121 | 0.004 | 0.121 | MAP kinase kinase 7 inhibitor | 0.112 0.006 CID_15366337 | ||
| 0.178 | 0.062 | 0.178 | Protein kinase (CK1) gamma 3 inhibitor | 0.133 0.11 CID_15366337 | ||
| 0.245 | 0.13 | 0.667 | Antithrombotic | 0.257 0.12 CID_15366337 0.667 0.01 CID_73707588 | CID_73707588 | |
| 0.142 | 0.027 | 0.155 | Urease inhibitor | 0.155 0.02 CID_15366337 | CID_15366337 | |
| 0.163 | 0.049 | 0.163 | Neurotrophic factor | 0.149 0.06 CID_15366337 0.141 0.067 CID_73707588 | ||
| 0.12 | 0.01 | 0.12 | NMDA 2C receptor antagonist | 0.094 0.018 CID_15366337 | ||
| 0.114 | 0.005 | 0.114 | GABA B receptor antagonist | 0.094 0.005 CID_15366337 | ||
| 0.144 | 0.035 | 0.168 | TRPA1 agonist | 0.168 0.021 CID_15366337 | CID_15366337 | |
| 0.116 | 0.008 | 0.116 | Beta 1 adrenoreceptor antagonist | 0.102 0.01 CID_15366337 | ||
| 0.162 | 0.054 | 0.337 | Cell wall synthesis inhibitor | 0.116 0.105 CID_15366337 0.337 0.008 CID_73707588 | CID_73707588 | |
| 0.212 | 0.105 | 0.363 | DNA synthesis inhibitor | 0.253 0.064 CID_15366337 0.363 0.028 CID_73707588 | CID_73707588 | |
| 0.129 | 0.022 | 0.133 | Macrophage migration inhibitory factor inhibitor | 0.133 0.021 CID_15366337 | CID_15366337 | |
| 0.12 | 0.013 | 0.136 | Bombesin 1 receptor agonist | 0.136 0.01 CID_15366337 | CID_15366337 | |
| 0.138 | 0.036 | 0.413 | AMP-activated protein kinase stimulant | 0.167 0.019 CID_15366337 0.413 0.004 CID_73707588 | CID_73707588 | |
| 0.125 | 0.024 | 0.125 | Protein kinase B gamma inhibitor | |||
| 0.131 | 0.03 | 0.131 | Protein kinase A inhibitor | |||
| 0.124 | 0.023 | 0.124 | Inducible nitric-oxide synthase inhibitor | 0.078 0.065 CID_15366337 | ||
| 0.109 | 0.01 | 0.109 | Dopamine D2 agonist | 0.061 0.02 CID_15366337 0.053 0.025 CID_73707588 | ||
| 0.133 | 0.033 | 0.232 | Antineoplastic alkaloid | 0.232 0.007 CID_15366337 | CID_15366337 | |
| 0.125 | 0.026 | 0.125 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.076 CID_15366337 | ||
| 0.219 | 0.121 | 0.271 | Gastrin inhibitor | 0.271 0.057 CID_15366337 | CID_15366337 | |
| 0.1 | 0.003 | 0.1 | 5 Hydroxytryptamine 6 agonist | 0.044 0.006 CID_15366337 | ||
| 0.187 | 0.09 | 0.298 | Neurotrophic factor enhancer | 0.298 0.018 CID_15366337 0.193 0.084 CID_73707588 | CID_15366337 | |
| 0.132 | 0.035 | 0.132 | Pim-1 kinase inhibitor | |||
| 0.141 | 0.044 | 0.171 | MAO A inhibitor | 0.171 0.036 CID_15366337 | CID_15366337 | |
| 0.187 | 0.091 | 0.198 | MAP kinase kinase 2 inhibitor | 0.198 0.083 CID_15366337 | CID_15366337 | |
| 0.182 | 0.086 | 0.182 | Death-associated protein kinase 3 inhibitor | 0.162 0.106 CID_15366337 | ||
| 0.1 | 0.005 | 0.1 | Somatostatin 5 agonist | 0.053 0.011 CID_15366337 0.04 0.019 CID_73707588 | ||
| 0.101 | 0.007 | 0.101 | Somatostatin 1 antagonist | 0.077 0.01 CID_15366337 0.057 0.016 CID_73707588 | ||
| 0.108 | 0.014 | 0.126 | CC chemokine 5 receptor agonist | 0.126 0.007 CID_15366337 | CID_15366337 | |
| 0.237 | 0.143 | 0.328 | Sodium/bile acid cotransporter inhibitor | 0.328 0.056 CID_15366337 | CID_15366337 | |
| 0.122 | 0.028 | 0.122 | Toll-Like receptor 3 antagonist | 0.088 0.074 CID_15366337 | ||
| 0.131 | 0.037 | 0.182 | Estrogen antagonist | 0.182 0.015 CID_15366337 | CID_15366337 | |
| 0.105 | 0.013 | 0.105 | 5 Hydroxytryptamine 6 antagonist | 0.065 0.033 CID_15366337 | ||
| 0.113 | 0.022 | 0.164 | Glycine receptor antagonist | 0.148 0.008 CID_15366337 0.164 0.005 CID_73707588 | CID_73707588 | |
| 0.132 | 0.042 | 0.132 | Transcription factor STAT6 inhibitor | |||
| 0.094 | 0.005 | 0.094 | Beta 2 adrenoreceptor agonist | 0.081 0.009 CID_15366337 | ||
| 0.219 | 0.13 | 0.272 | Hypoxia-inducible factor 1 alpha inhibitor | 0.272 0.082 CID_15366337 0.246 0.104 CID_73707588 | CID_15366337 | |
| 0.106 | 0.017 | 0.106 | Carbonic anhydrase stimulant | 0.064 0.036 CID_15366337 | ||
| 0.124 | 0.035 | 0.124 | Opioid antagonist | 0.094 0.052 CID_15366337 | ||
| 0.192 | 0.103 | 0.208 | Dyrk kinase inhibitor | 0.208 0.094 CID_15366337 | CID_15366337 | |
| 0.143 | 0.057 | 0.167 | Interleukin 4 antagonist | 0.167 0.037 CID_15366337 0.139 0.061 CID_73707588 | CID_15366337 | |
| 0.094 | 0.009 | 0.096 | Beta 2 adrenoreceptor antagonist | 0.096 0.008 CID_15366337 | CID_15366337 | |
| 0.18 | 0.095 | 0.206 | Insulin sensitizer | 0.206 0.067 CID_15366337 0.176 0.1 CID_73707588 | CID_15366337 | |
| 0.092 | 0.007 | 0.092 | Somatostatin 2 antagonist | 0.062 0.011 CID_15366337 0.041 0.018 CID_73707588 | ||
| 0.166 | 0.081 | 0.166 | Tumour necrosis factor antagonist | 0.138 0.116 CID_15366337 | ||
| 0.11 | 0.025 | 0.125 | Keratolytic | 0.125 0.02 CID_15366337 | CID_15366337 | |
| 0.136 | 0.053 | 0.305 | Monophenol monooxygenase inhibitor | 0.18 0.038 CID_15366337 0.305 0.017 CID_73707588 | CID_73707588 | |
| 0.1 | 0.017 | 0.1 | Alpha 1 adrenoreceptor agonist | 0.057 0.04 CID_15366337 | ||
| 0.088 | 0.004 | 0.088 | 5 Hydroxytryptamine 2B agonist | 0.058 0.009 CID_15366337 | ||
| 0.09 | 0.007 | 0.09 | Somatostatin 4 agonist | 0.089 0.008 CID_15366337 | ||
| 0.105 | 0.023 | 0.105 | Dopamine D1 antagonist | 0.102 0.024 CID_15366337 | ||
| 0.143 | 0.061 | 0.143 | Nav1.2 sodium channel blocker | 0.126 0.077 CID_15366337 | ||
| 0.213 | 0.131 | 0.213 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.196 0.178 CID_15366337 | ||
| 0.096 | 0.014 | 0.096 | Bombesin 2 receptor antagonist | 0.072 0.019 CID_15366337 | ||
| 0.134 | 0.053 | 0.163 | Beta amyloid protein antagonist | 0.163 0.032 CID_15366337 0.158 0.035 CID_73707588 | CID_15366337 | |
| 0.097 | 0.016 | 0.144 | GABA receptor antagonist | 0.144 0.01 CID_15366337 | CID_15366337 | |
| 0.138 | 0.058 | 0.143 | Antibacterial (Helicobacter pylori) | 0.143 0.053 CID_15366337 | CID_15366337 | |
| 0.117 | 0.037 | 0.189 | Alcohol dehydrogenase inhibitor | 0.189 0.014 CID_15366337 0.092 0.062 CID_73707588 | CID_15366337 | |
| 0.096 | 0.016 | 0.103 | Alpha 2 adrenoreceptor agonist | 0.103 0.014 CID_15366337 | CID_15366337 | |
| 0.183 | 0.104 | 0.21 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.21 0.086 CID_15366337 | CID_15366337 | |
| 0.089 | 0.01 | 0.101 | Cholecystokinin A antagonist | 0.101 0.008 CID_15366337 | CID_15366337 | |
| 0.084 | 0.006 | 0.084 | Histamine H2 receptor agonist | 0.047 0.025 CID_15366337 | ||
| 0.113 | 0.036 | 0.128 | Interleukin 12 antagonist | 0.118 0.031 CID_15366337 0.128 0.022 CID_73707588 | CID_73707588 | |
| 0.085 | 0.008 | 0.085 | Somatostatin 5 antagonist | 0.059 0.01 CID_15366337 0.046 0.015 CID_73707588 | ||
| 0.086 | 0.008 | 0.086 | Growth hormone release inhibitor | 0.066 0.013 CID_15366337 0.047 0.024 CID_73707588 | ||
| 0.084 | 0.007 | 0.1 | Adenylate cyclase 1 inhibitor | 0.1 0.004 CID_15366337 | CID_15366337 | |
| 0.1 | 0.025 | 0.1 | CXC chemokine 4 receptor antagonist | |||
| 0.08 | 0.004 | 0.08 | Bombesin 1 receptor antagonist | 0.075 0.005 CID_15366337 0.034 0.029 CID_73707588 | ||
| 0.08 | 0.005 | 0.08 | Dopamine beta hydroxylase inhibitor | 0.05 0.03 CID_15366337 | ||
| 0.081 | 0.006 | 0.081 | GHS receptor agonist | 0.066 0.01 CID_15366337 | ||
| 0.124 | 0.05 | 0.124 | Chelator | 0.109 0.065 CID_15366337 | ||
| 0.105 | 0.03 | 0.105 | Opioid mu receptor antagonist | 0.073 0.044 CID_15366337 | ||
| 0.14 | 0.066 | 0.159 | Nav1.6 sodium channel blocker | 0.159 0.045 CID_15366337 | CID_15366337 | |
| 0.099 | 0.026 | 0.102 | Estrogen-related receptor beta agonist | 0.102 0.023 CID_15366337 | CID_15366337 | |
| 0.102 | 0.029 | 0.102 | Opioid delta receptor antagonist | 0.064 0.044 CID_15366337 | ||
| 0.091 | 0.019 | 0.091 | Protein kinase C beta inhibitor | 0.085 0.024 CID_15366337 | ||
| 0.144 | 0.072 | 0.259 | Lipid peroxidase inhibitor | 0.201 0.041 CID_15366337 0.259 0.025 CID_73707588 | CID_73707588 | |
| 0.105 | 0.034 | 0.105 | Alpha 1b adrenoreceptor antagonist | 0.077 0.048 CID_15366337 | ||
| 0.106 | 0.034 | 0.106 | I kappa B kinase inhibitor | |||
| 0.075 | 0.005 | 0.075 | Beta adrenoreceptor agonist | 0.06 0.008 CID_15366337 | ||
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.074 0.009 CID_15366337 | ||
| 0.095 | 0.025 | 0.095 | Sirtuin 1 inhibitor | 0.066 0.05 CID_15366337 | ||
| 0.142 | 0.073 | 0.167 | MAP3K9 inhibitor | 0.167 0.038 CID_15366337 | CID_15366337 | |
| 0.19 | 0.123 | 0.221 | Calpain inhibitor | 0.221 0.094 CID_15366337 | CID_15366337 | |
| 0.111 | 0.044 | 0.151 | Estrogen receptor beta antagonist | 0.151 0.015 CID_15366337 | CID_15366337 | |
| 0.104 | 0.037 | 0.104 | Acetylcholine nicotinic antagonist | 0.085 0.05 CID_15366337 | ||
| 0.076 | 0.01 | 0.076 | Growth hormone secretagogue receptor antagonist | 0.054 0.016 CID_15366337 | ||
| 0.082 | 0.016 | 0.099 | Cyclin D1 inhibitor | 0.099 0.008 CID_15366337 | CID_15366337 | |
| 0.095 | 0.03 | 0.095 | Check point kinase 1 inhibitor | |||
| 0.102 | 0.037 | 0.106 | Carbonic anhydrase XIII inhibitor | 0.106 0.035 CID_73707588 | CID_73707588 | |
| 0.1 | 0.035 | 0.1 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.106 | 0.042 | 0.215 | Triose-phosphate isomerase inhibitor | 0.127 0.029 CID_15366337 0.215 0.009 CID_73707588 | CID_73707588 | |
| 0.076 | 0.012 | 0.094 | Cholecystokinin antagonist | 0.094 0.009 CID_15366337 | CID_15366337 | |
| 0.138 | 0.074 | 0.138 | Glycogen synthase kinase-3 alpha inhibitor | 0.118 0.086 CID_15366337 | ||
| 0.13 | 0.067 | 0.325 | Cyclooxygenase 3 inhibitor | 0.16 0.04 CID_15366337 0.325 0.005 CID_73707588 | CID_73707588 | |
| 0.068 | 0.005 | 0.068 | Melatonin antagonist | 0.035 0.013 CID_15366337 | ||
| 0.067 | 0.005 | 0.067 | Melatonin 1 agonist | 0.065 0.006 CID_15366337 0.04 0.015 CID_73707588 | ||
| 0.09 | 0.029 | 0.09 | Neuronal nicotinic receptor antagonist | 0.081 0.035 CID_15366337 | ||
| 0.073 | 0.012 | 0.073 | Kinesin-like protein 1 inhibitor | |||
| 0.073 | 0.012 | 0.073 | Kinesin antagonist | |||
| 0.168 | 0.106 | 0.168 | Growth factor agonist | 0.168 0.105 CID_15366337 | ||
| 0.083 | 0.022 | 0.083 | Protein kinase C eta inhibitor | 0.066 0.031 CID_15366337 0.049 0.045 CID_73707588 | ||
| 0.065 | 0.005 | 0.07 | Melatonin receptor 1A agonist | 0.07 0.004 CID_15366337 | CID_15366337 | |
| 0.075 | 0.015 | 0.076 | Prolactin release inhibitor | 0.076 0.014 CID_15366337 | CID_15366337 | |
| 0.095 | 0.035 | 0.104 | D-Ala-D-Ala ligase inhibitor | 0.104 0.025 CID_15366337 | CID_15366337 | |
| 0.125 | 0.065 | 0.125 | Histone deacetylase class III inhibitor | |||
| 0.088 | 0.028 | 0.088 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.066 | 0.006 | 0.066 | Melatonin agonist | 0.066 0.006 CID_15366337 0.032 0.024 CID_73707588 | ||
| 0.089 | 0.03 | 0.089 | 5 Hydroxytryptamine uptake inhibitor | 0.061 0.046 CID_15366337 | ||
| 0.078 | 0.02 | 0.078 | Protein kinase C epsilon inhibitor | |||
| 0.118 | 0.059 | 0.153 | Cystathionine beta-synthase inhibitor | 0.153 0.039 CID_15366337 0.093 0.086 CID_73707588 | CID_15366337 | |
| 0.078 | 0.02 | 0.078 | Histone deacetylase SIRT3 inhibitor | 0.062 0.042 CID_15366337 | ||
| 0.08 | 0.022 | 0.08 | Carbonic anhydrase VB inhibitor | |||
| 0.112 | 0.054 | 0.112 | MAO B inhibitor | |||
| 0.14 | 0.083 | 0.14 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.125 0.101 CID_15366337 | ||
| 0.082 | 0.025 | 0.105 | Aryl hydrocarbon receptor antagonist | 0.105 0.012 CID_15366337 | CID_15366337 | |
| 0.143 | 0.086 | 0.152 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.152 0.068 CID_15366337 | CID_15366337 | |
| 0.138 | 0.082 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.156 0.03 CID_15366337 0.134 0.101 CID_73707588 | CID_15366337 | |
| 0.071 | 0.015 | 0.103 | NMDA receptor subunit 3B antagonist | 0.103 0.01 CID_15366337 | CID_15366337 | |
| 0.069 | 0.013 | 0.069 | Bombesin antagonist | 0.066 0.014 CID_15366337 | ||
| 0.096 | 0.042 | 0.096 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.076 | 0.023 | 0.141 | GABA A receptor antagonist | 0.141 0.01 CID_15366337 | CID_15366337 | |
| 0.06 | 0.007 | 0.06 | Somatostatin 4 antagonist | 0.032 0.011 CID_15366337 0.028 0.013 CID_73707588 | ||
| 0.258 | 0.206 | 0.511 | Apoptosis agonist | 0.343 0.143 CID_15366337 0.511 0.071 CID_73707588 | CID_73707588 | |
| 0.106 | 0.053 | 0.106 | Alpha adrenoreceptor antagonist | |||
| 0.202 | 0.15 | 0.313 | 12-Lipoxygenase inhibitor | 0.313 0.072 CID_15366337 | CID_15366337 | |
| 0.058 | 0.006 | 0.058 | Dopamine autoreceptor agonist | 0.036 0.011 CID_15366337 | ||
| 0.072 | 0.02 | 0.072 | Nicotinic receptor alpha7 subunit antagonist | 0.06 0.028 CID_15366337 | ||
| 0.134 | 0.083 | 0.134 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.087 | 0.037 | 0.087 | Protein kinase B alpha inhibitor | 0.065 0.053 CID_15366337 | ||
| 0.195 | 0.145 | 0.268 | Lipoxygenase inhibitor | 0.268 0.088 CID_15366337 | CID_15366337 | |
| 0.058 | 0.008 | 0.06 | Melatonin 2 agonist | 0.06 0.008 CID_15366337 0.04 0.016 CID_73707588 | CID_15366337 | |
| 0.097 | 0.048 | 0.097 | Pim-3 kinase inhibitor | 0.095 0.051 CID_15366337 | ||
| 0.106 | 0.057 | 0.106 | Bronchodilator | 0.103 0.061 CID_15366337 | ||
| 0.072 | 0.023 | 0.072 | Pim-2 kinase inhibitor | |||
| 0.103 | 0.054 | 0.103 | Antiadrenergic | |||
| 0.082 | 0.035 | 0.082 | I kappa B kinase 1 inhibitor | |||
| 0.071 | 0.024 | 0.071 | Gonadotropin-releasing hormone receptor agonist | 0.069 0.027 CID_15366337 | ||
| 0.101 | 0.054 | 0.129 | Breast cancer-resistant protein inhibitor | 0.129 0.034 CID_15366337 | CID_15366337 | |
| 0.07 | 0.023 | 0.07 | Protein kinase C theta inhibitor | 0.064 0.031 CID_15366337 | ||
| 0.153 | 0.107 | 0.181 | Succinate dehydrogenase inhibitor | 0.181 0.066 CID_15366337 | CID_15366337 | |
| 0.085 | 0.04 | 0.085 | GABA aminotransferase inhibitor | 0.073 0.056 CID_15366337 0.075 0.053 CID_73707588 | ||
| 0.056 | 0.012 | 0.056 | Histamine H1 receptor agonist | |||
| 0.11 | 0.066 | 0.118 | Acetylcholine release stimulant | 0.116 0.054 CID_15366337 0.118 0.051 CID_73707588 | CID_73707588 | |
| 0.063 | 0.019 | 0.063 | Melanocortin antagonist | |||
| 0.08 | 0.036 | 0.08 | Carbonic anhydrase VA inhibitor | |||
| 0.091 | 0.048 | 0.091 | Factor XII inhibitor | 0.085 0.057 CID_15366337 | ||
| 0.097 | 0.055 | 0.097 | Adrenaline antagonist | |||
| 0.086 | 0.044 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 CID_73707588 | CID_73707588 | |
| 0.074 | 0.033 | 0.074 | NMDA receptor agonist | |||
| 0.177 | 0.136 | 0.177 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.09 | 0.049 | 0.09 | Hematopoietic | |||
| 0.047 | 0.007 | 0.047 | Somatostatin 3 antagonist | 0.029 0.009 CID_15366337 0.018 0.016 CID_73707588 | ||
| 0.069 | 0.029 | 0.095 | Heat shock protein 90 beta antagonist | 0.095 0.013 CID_15366337 | CID_15366337 | |
| 0.071 | 0.031 | 0.071 | I kappa B kinase 2 inhibitor | |||
| 0.053 | 0.014 | 0.053 | Cholecystokinin B agonist | 0.053 0.014 CID_15366337 | ||
| 0.148 | 0.109 | 0.183 | Catenin beta inhibitor | 0.183 0.048 CID_15366337 | CID_15366337 | |
| 0.047 | 0.008 | 0.052 | GHS receptor antagonist | 0.052 0.007 CID_15366337 | CID_15366337 | |
| 0.053 | 0.015 | 0.053 | Carbonic anhydrase I stimulant | |||
| 0.063 | 0.025 | 0.063 | Histamine agonist | |||
| 0.075 | 0.038 | 0.086 | Glucagon-like peptide 1 agonist | 0.086 0.031 CID_15366337 | CID_15366337 | |
| 0.041 | 0.005 | 0.041 | Beta 1 adrenoreceptor agonist | 0.03 0.008 CID_15366337 | ||
| 0.087 | 0.051 | 0.087 | Histamine H2 receptor antagonist | |||
| 0.09 | 0.055 | 0.09 | Ornithine decarboxylase inhibitor | |||
| 0.077 | 0.043 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.055 CID_15366337 | ||
| 0.059 | 0.025 | 0.059 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.04 | 0.006 | 0.068 | Thyroid hormone agonist | 0.068 0.003 CID_15366337 | CID_15366337 | |
| 0.057 | 0.023 | 0.057 | 5 Hydroxytryptamine 2C agonist | |||
| 0.073 | 0.04 | 0.073 | Carbonic anhydrase V inhibitor | |||
| 0.061 | 0.029 | 0.145 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.145 0.005 CID_15366337 | CID_15366337 | |
| 0.054 | 0.021 | 0.054 | Melanocortin 4 antagonist | |||
| 0.048 | 0.016 | 0.048 | AMPA 4 receptor antagonist | 0.04 0.026 CID_15366337 | ||
| 0.109 | 0.078 | 0.218 | Topoisomerase II inhibitor | 0.121 0.066 CID_15366337 0.218 0.029 CID_73707588 | CID_73707588 | |
| 0.039 | 0.008 | 0.048 | Follicle-stimulating hormone agonist | 0.048 0.006 CID_15366337 | CID_15366337 | |
| 0.055 | 0.026 | 0.055 | Opioid mu receptor agonist | 0.05 0.028 CID_15366337 | ||
| 0.072 | 0.043 | 0.072 | Dopamine D2 antagonist | 0.063 0.048 CID_15366337 | ||
| 0.111 | 0.083 | 0.111 | Cholinergic antagonist | |||
| 0.112 | 0.083 | 0.112 | Glutamate receptor antagonist | |||
| 0.048 | 0.02 | 0.048 | Melanocortin 1 antagonist | 0.036 0.028 CID_15366337 | ||
| 0.077 | 0.049 | 0.077 | Dopamine antagonist | 0.075 0.05 CID_15366337 | ||
| 0.075 | 0.048 | 0.075 | Protein kinase B beta inhibitor | |||
| 0.044 | 0.017 | 0.044 | 5 Hydroxytryptamine 3B antagonist | 0.032 0.03 CID_15366337 | ||
| 0.031 | 0.005 | 0.038 | Follicle-stimulating hormone antagonist | 0.038 0.004 CID_15366337 | CID_15366337 | |
| 0.048 | 0.021 | 0.082 | NMDA receptor subunit 3A antagonist | 0.082 0.011 CID_15366337 | CID_15366337 | |
| 0.064 | 0.038 | 0.064 | Alpha 1d adrenoreceptor antagonist | 0.055 0.045 CID_15366337 | ||
| 0.054 | 0.028 | 0.056 | Endothelin-converting enzyme inhibitor | 0.056 0.027 CID_15366337 | CID_15366337 | |
| 0.04 | 0.014 | 0.048 | Cholecystokinin B antagonist | 0.048 0.011 CID_15366337 | CID_15366337 | |
| 0.108 | 0.082 | 0.108 | Acetylcholine antagonist | |||
| 0.086 | 0.06 | 0.106 | Granulocyte macrophage colony stimulating factor agonist | 0.106 0.027 CID_15366337 | CID_15366337 | |
| 0.059 | 0.034 | 0.073 | Bombesin 3 receptor antagonist | 0.073 0.023 CID_15366337 | CID_15366337 | |
| 0.04 | 0.015 | 0.04 | AMPA 1 receptor antagonist | 0.036 0.017 CID_15366337 | ||
| 0.081 | 0.056 | 0.081 | Opioid kappa receptor antagonist | |||
| 0.038 | 0.013 | 0.056 | Estrogen-related receptor beta antagonist | 0.056 0.005 CID_15366337 | CID_15366337 | |
| 0.033 | 0.008 | 0.036 | Dopamine D1 agonist | 0.025 0.013 CID_15366337 0.036 0.006 CID_73707588 | CID_73707588 | |
| 0.029 | 0.005 | 0.029 | Somatostatin 2 agonist | 0.02 0.006 CID_15366337 | ||
| 0.035 | 0.012 | 0.035 | Urotensin II agonist | |||
| 0.029 | 0.007 | 0.029 | Melatonin 1 antagonist | 0.019 0.013 CID_15366337 | ||
| 0.119 | 0.096 | 0.119 | CDC-like kinase 1 inhibitor | 0.113 0.103 CID_15366337 | ||
| 0.136 | 0.113 | 0.212 | Interleukin 6 antagonist | 0.176 0.058 CID_15366337 0.212 0.034 CID_73707588 | CID_73707588 | |
| 0.091 | 0.07 | 0.129 | Bile acid receptor antagonist | 0.129 0.014 CID_15366337 | CID_15366337 | |
| 0.118 | 0.097 | 0.118 | Vascular endothelial growth factor 3 antagonist | |||
| 0.125 | 0.105 | 0.192 | Heat shock protein 90 antagonist | 0.192 0.042 CID_15366337 | CID_15366337 | |
| 0.025 | 0.005 | 0.025 | Somatostatin 3 agonist | 0.023 0.007 CID_15366337 | ||
| 0.053 | 0.034 | 0.053 | Carbonic anhydrase II stimulant | |||
| 0.046 | 0.028 | 0.049 | Geranyltranstransferase inhibitor | 0.049 0.024 CID_15366337 | CID_15366337 | |
| 0.045 | 0.027 | 0.045 | Oxytocin agonist | 0.039 0.033 CID_15366337 | ||
| 0.15 | 0.132 | 0.15 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.15 0.133 CID_15366337 | ||
| 0.074 | 0.056 | 0.121 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.121 0.029 CID_15366337 | CID_15366337 | |
| 0.091 | 0.073 | 0.131 | Phosphodiesterase 6D inhibitor | 0.113 0.032 CID_15366337 0.131 0.017 CID_73707588 | CID_73707588 | |
| 0.037 | 0.02 | 0.037 | Growth hormone releasing factor agonist | |||
| 0.083 | 0.068 | 0.142 | NADH dehydrogenase inhibitor | 0.091 0.055 CID_15366337 0.142 0.02 CID_73707588 | CID_73707588 | |
| 0.087 | 0.071 | 0.087 | Protein kinase C mu inhibitor | |||
| 0.04 | 0.025 | 0.044 | Histone deacetylase 9 inhibitor | 0.044 0.02 CID_15366337 | CID_15366337 | |
| 0.037 | 0.023 | 0.037 | Opioid delta receptor agonist | 0.032 0.03 CID_15366337 | ||
| 0.028 | 0.014 | 0.028 | Growth hormone releasing factor antagonist | |||
| 0.073 | 0.06 | 0.114 | Estrogen receptor alpha antagonist | 0.114 0.021 CID_15366337 | CID_15366337 | |
| 0.072 | 0.059 | 0.072 | Analgesic, opioid | |||
| 0.092 | 0.079 | 0.205 | Mediator release inhibitor | 0.113 0.055 CID_15366337 0.205 0.014 CID_73707588 | CID_73707588 | |
| 0.038 | 0.026 | 0.038 | Leukotriene A4 hydrolase inhibitor | |||
| 0.1 | 0.088 | 0.208 | Alkylator | 0.208 0.024 CID_73707588 | CID_73707588 | |
| 0.114 | 0.102 | 0.13 | Vanilloid 1 agonist | 0.13 0.067 CID_15366337 | CID_15366337 | |
| 0.034 | 0.022 | 0.034 | Sirtuin 2 inhibitor | |||
| 0.028 | 0.017 | 0.028 | Melanocortin 5 antagonist | |||
| 0.044 | 0.032 | 0.044 | Neurotensin receptor antagonist | |||
| 0.04 | 0.029 | 0.04 | Toll-Like receptor 2 agonist | 0.039 0.03 CID_73707588 | ||
| 0.069 | 0.058 | 0.069 | Glutamate dehydrogenase inhibitor | |||
| 0.078 | 0.067 | 0.093 | GABA A receptor agonist | 0.093 0.045 CID_15366337 | CID_15366337 | |
| 0.067 | 0.057 | 0.099 | Catalase inhibitor | 0.099 0.039 CID_15366337 | CID_15366337 | |
| 0.042 | 0.031 | 0.042 | Complement C3a chemotactic receptor antagonist | |||
| 0.038 | 0.027 | 0.038 | TRPM8 blocker | |||
| 0.03 | 0.02 | 0.03 | AMPA 3 receptor antagonist | |||
| 0.097 | 0.087 | 0.097 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.192 | 0.182 | 0.254 | Caspase 3 stimulant | 0.242 0.12 CID_15366337 0.254 0.108 CID_73707588 | CID_73707588 | |
| 0.062 | 0.052 | 0.062 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.144 | 0.135 | 0.24 | EphB2 antagonist | 0.24 0.063 CID_15366337 | CID_15366337 | |
| 0.052 | 0.043 | 0.052 | Epithelial sodium channel blocker | |||
| 0.036 | 0.027 | 0.045 | Histone deacetylase 7 inhibitor | 0.045 0.02 CID_15366337 | CID_15366337 | |
| 0.063 | 0.055 | 0.063 | Protein kinase C alpha inhibitor | |||
| 0.036 | 0.028 | 0.036 | Diamine oxidase inhibitor | |||
| 0.156 | 0.148 | 0.311 | Vasodilator | 0.311 0.044 CID_73707588 | CID_73707588 | |
| 0.136 | 0.128 | 0.247 | 3C-like protease (Human coronavirus) inhibitor | 0.247 0.029 CID_15366337 | CID_15366337 | |
| 0.028 | 0.02 | 0.028 | Melanocortin 3 antagonist | |||
| 0.014 | 0.006 | 0.014 | Beta 3 adrenoreceptor agonist | 0.013 0.007 CID_15366337 | ||
| 0.042 | 0.034 | 0.042 | AICAR transformylase inhibitor | |||
| 0.019 | 0.013 | 0.019 | Melatonin 3 antagonist | |||
| 0.066 | 0.059 | 0.066 | Aminopeptidase I inhibitor | |||
| 0.034 | 0.028 | 0.065 | Arginase inhibitor | 0.065 0.009 CID_73707588 | CID_73707588 | |
| 0.019 | 0.013 | 0.037 | Cholecystokinin agonist | 0.037 0.009 CID_15366337 | CID_15366337 | |
| 0.064 | 0.059 | 0.07 | MDM2 inhibitor | 0.07 0.039 CID_15366337 | CID_15366337 | |
| 0.022 | 0.017 | 0.027 | ICAM 1 antagonist | 0.027 0.009 CID_15366337 | CID_15366337 | |
| 0.058 | 0.053 | 0.062 | Neutrophil collagenase inhibitor | 0.062 0.049 CID_15366337 | CID_15366337 | |
| 0.048 | 0.043 | 0.048 | Opioid agonist | |||
| 0.017 | 0.012 | 0.017 | KiSS-1 receptor antagonist | |||
| 0.027 | 0.022 | 0.028 | Nicotinic alpha4beta2 receptor agonist | 0.028 0.02 CID_15366337 | CID_15366337 | |
| 0.177 | 0.173 | 0.177 | Transcription factor STAT inhibitor | |||
| 0.05 | 0.047 | 0.056 | Argininosuccinate synthase inhibitor | 0.056 0.04 CID_15366337 | CID_15366337 | |
| 0.041 | 0.038 | 0.041 | Urokinase inhibitor | |||
| 0.015 | 0.012 | 0.024 | Cholecystokinin A agonist | 0.024 0.007 CID_15366337 | CID_15366337 | |
| 0.087 | 0.084 | 0.121 | Anabolic | 0.121 0.039 CID_15366337 | CID_15366337 | |
| 0.021 | 0.018 | 0.022 | Bombesin agonist | 0.022 0.016 CID_15366337 | CID_15366337 | |
| 0.023 | 0.021 | 0.023 | Sigma 2 receptor antagonist | |||
| 0.055 | 0.053 | 0.057 | Ryanodine receptor antagonist | 0.057 0.049 CID_15366337 | CID_15366337 | |
| 0.017 | 0.015 | 0.017 | Histamine H4 receptor agonist | |||
| 0.008 | 0.007 | 0.026 | Thyroid hormone beta agonist | 0.026 0.003 CID_15366337 | CID_15366337 | |
| 0.052 | 0.051 | 0.052 | Botulinum neurotoxin type A inhibitor | |||
| 0.057 | 0.056 | 0.079 | CDC25B inhibitor | 0.079 0.028 CID_15366337 | CID_15366337 | |
| 0.017 | 0.016 | 0.017 | Growth hormone release promoting | |||
| 0.094 | 0.093 | 0.094 | CDC-like kinase 3 inhibitor | |||
| 0.035 | 0.034 | 0.035 | Dopamine D3 agonist | |||
| 0.05 | 0.049 | 0.05 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.098 | 0.098 | 0.328 | Amylase inhibitor | 0.177 0.052 CID_15366337 0.328 0.015 CID_73707588 | CID_73707588 | |
| 0.158 | 0.159 | 0.301 | Interleukin agonist | 0.301 0.047 CID_73707588 | CID_73707588 | |
| 0.136 | 0.138 | 0.138 | Antimitotic | 0.138 0.134 CID_15366337 | CID_15366337 | |
| 0.01 | 0.013 | 0.014 | Melatonin 2 antagonist | 0.014 0.006 CID_15366337 | CID_15366337 | |
| 0.083 | 0.086 | 0.142 | Xanthine oxidase inhibitor | 0.142 0.037 CID_15366337 0.141 0.038 CID_73707588 | CID_15366337 | |
| 0.064 | 0.068 | 0.133 | Topoisomerase II alpha inhibitor | 0.133 0.026 CID_73707588 | CID_73707588 | |
| 0.082 | 0.087 | 0.18 | UDP-glucose 4-epimerase inhibitor | 0.129 0.038 CID_15366337 0.18 0.021 CID_73707588 | CID_73707588 | |
| 0.086 | 0.092 | 0.148 | DNA intercalator | 0.106 0.068 CID_15366337 0.148 0.044 CID_73707588 | CID_73707588 | |
| 0.01 | 0.018 | 0.016 | Melatonin receptor 1A antagonist | 0.016 0.008 CID_15366337 | CID_15366337 | |
| 0.028 | 0.036 | 0.034 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.034 0.024 CID_15366337 | CID_15366337 | |
| 0.063 | 0.071 | 0.07 | Metalloproteinase-9 inhibitor | 0.07 0.056 CID_15366337 | CID_15366337 | |
| 0.129 | 0.138 | 0.196 | Anesthetic general | 0.196 0.077 CID_15366337 | CID_15366337 | |
| 0.067 | 0.076 | 0.09 | Interferon agonist | 0.071 0.069 CID_15366337 0.09 0.038 CID_73707588 | CID_73707588 | |
| 0.087 | 0.096 | 0.159 | Toll-Like receptor 4 antagonist | 0.159 0.016 CID_73707588 | CID_73707588 | |
| 0.074 | 0.083 | 0.116 | Falcipain inhibitor | 0.08 0.074 CID_15366337 0.116 0.046 CID_73707588 | CID_73707588 | |
| 0.036 | 0.046 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.024 CID_15366337 | CID_15366337 | |
| 0.083 | 0.093 | 0.108 | Ferrochelatase inhibitor | 0.108 0.063 CID_15366337 | CID_15366337 | |
| 0.071 | 0.082 | 0.113 | Falcipain 2 inhibitor | 0.078 0.072 CID_15366337 0.113 0.045 CID_73707588 | CID_73707588 | |
| 0.147 | 0.158 | 0.284 | Cyclic AMP phosphodiesterase inhibitor | 0.284 0.048 CID_15366337 0.272 0.053 CID_73707588 | CID_15366337 | |
| 0.039 | 0.05 | 0.061 | Carbonic anhydrase XIV inhibitor | 0.061 0.024 CID_73707588 | CID_73707588 | |
| 0.035 | 0.047 | 0.05 | Adenosine deaminase inhibitor | 0.05 0.031 CID_15366337 | CID_15366337 | |
| 0.12 | 0.133 | 0.205 | Interferon gamma antagonist | 0.164 0.062 CID_15366337 0.205 0.039 CID_73707588 | CID_73707588 | |
| 0.055 | 0.069 | 0.07 | Interferon inducer | 0.07 0.035 CID_73707588 | CID_73707588 | |
| 0.024 | 0.038 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.025 CID_15366337 | CID_15366337 | |
| 0.047 | 0.062 | 0.109 | Androgen agonist | 0.109 0.012 CID_15366337 | CID_15366337 | |
| 0.018 | 0.033 | 0.044 | Uridine phosphorylase inhibitor | 0.044 0.01 CID_15366337 0.03 0.017 CID_73707588 | CID_15366337 | |
| 0.029 | 0.045 | 0.037 | Histone deacetylase 8 inhibitor | 0.037 0.033 CID_15366337 | CID_15366337 | |
| 0.012 | 0.027 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.009 CID_15366337 | CID_15366337 | |
| 0.046 | 0.062 | 0.053 | Dopamine D3 antagonist | 0.053 0.052 CID_15366337 | CID_15366337 | |
| 0.021 | 0.038 | 0.026 | Thymidine phosphorylase inhibitor | 0.026 0.017 CID_15366337 | CID_15366337 | |
| 0.119 | 0.137 | 0.329 | Nitric oxide antagonist | 0.14 0.105 CID_15366337 0.329 0.035 CID_73707588 | CID_73707588 | |
| 0.04 | 0.058 | 0.052 | Topoisomerase II beta inhibitor | 0.052 0.03 CID_15366337 | CID_15366337 | |
| 0.04 | 0.06 | 0.051 | Dopamine D4 antagonist | 0.051 0.048 CID_15366337 | CID_15366337 | |
| 0.131 | 0.152 | 0.155 | Cyclin-dependent kinase 3 inhibitor | 0.155 0.085 CID_15366337 | CID_15366337 | |
| 0.043 | 0.064 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 CID_15366337 0.05 0.048 CID_73707588 | CID_15366337 | |
| 0.045 | 0.067 | 0.346 | Selectin antagonist | 0.346 0.004 CID_73707588 | CID_73707588 | |
| 0.034 | 0.059 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.027 CID_15366337 | CID_15366337 | |
| 0.06 | 0.086 | 0.07 | Metalloproteinase-2 inhibitor | 0.07 0.065 CID_15366337 | CID_15366337 | |
| 0.078 | 0.104 | 0.091 | Polo-like kinase-4 inhibitor | 0.091 0.087 CID_15366337 | CID_15366337 | |
| 0.037 | 0.063 | 0.066 | Aromatase inhibitor | 0.066 0.037 CID_15366337 | CID_15366337 | |
| 0.105 | 0.131 | 0.119 | Papain-like protease (SARS coronavirus) inhibitor | 0.119 0.083 CID_15366337 | CID_15366337 | |
| 0.109 | 0.138 | 0.247 | NOS3 expression enhancer | 0.165 0.059 CID_15366337 0.247 0.027 CID_73707588 | CID_73707588 | |
| 0.07 | 0.102 | 0.088 | Interleukin 5 antagonist | 0.088 0.057 CID_15366337 | CID_15366337 | |
| 0.031 | 0.063 | 0.088 | Mannosidase inhibitor | 0.088 0.007 CID_73707588 | CID_73707588 | |
| 0.03 | 0.063 | 0.044 | Thymidylate synthase inhibitor | 0.044 0.036 CID_15366337 | CID_15366337 | |
| 0.079 | 0.113 | 0.125 | DNA polymerase I inhibitor | 0.125 0.064 CID_73707588 | CID_73707588 | |
| 0.011 | 0.045 | 0.079 | Estrogen receptor beta agonist | 0.079 0.014 CID_15366337 | CID_15366337 | |
| 0.149 | 0.184 | 0.173 | ErbB-1 antagonist | 0.173 0.128 CID_15366337 | CID_15366337 | |
| 0.054 | 0.09 | 0.064 | Calcium channel P-type blocker | 0.064 0.042 CID_15366337 | CID_15366337 | |
| 0.081 | 0.117 | 0.117 | Proteasome inhibitor | 0.117 0.068 CID_15366337 | CID_15366337 | |
| 0.009 | 0.046 | 0.022 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.022 0.012 CID_15366337 | CID_15366337 | |
| 0.033 | 0.07 | 0.062 | Xanthine dehydrogenase inhibitor | 0.062 0.037 CID_15366337 | CID_15366337 | |
| 0.033 | 0.07 | 0.053 | Mineralocorticoid receptor antagonist | 0.053 0.027 CID_15366337 | CID_15366337 | |
| 0.019 | 0.057 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_73707588 | CID_73707588 | |
| 0.025 | 0.063 | 0.071 | Antibiotic Aminoglycoside-like | 0.071 0.006 CID_73707588 | CID_73707588 | |
| 0.042 | 0.082 | 0.109 | Phosphofructokinase-1 inhibitor | 0.076 0.044 CID_15366337 0.109 0.028 CID_73707588 | CID_73707588 | |
| 0.013 | 0.053 | 0.027 | Cyclin E2 inhibitor | 0.027 0.022 CID_15366337 | CID_15366337 | |
| 0.085 | 0.127 | 0.111 | Bone formation stimulant | 0.111 0.095 CID_15366337 | CID_15366337 | |
| 0.106 | 0.148 | 0.187 | Arachidonic acid antagonist | 0.187 0.046 CID_15366337 | CID_15366337 | |
| 0.039 | 0.082 | 0.051 | Factor III inhibitor | 0.051 0.033 CID_73707588 | CID_73707588 | |
| 0.051 | 0.094 | 0.076 | MAP3K7 inhibitor | 0.076 0.045 CID_15366337 | CID_15366337 | |
| 0.009 | 0.052 | 0.045 | Estrogen receptor alpha agonist | 0.045 0.019 CID_15366337 | CID_15366337 | |
| 0.035 | 0.078 | 0.066 | Cyclin B2 inhibitor | 0.066 0.025 CID_15366337 | CID_15366337 | |
| 0.037 | 0.081 | 0.081 | Alpha-mannosidase inhibitor | 0.081 0.011 CID_73707588 | CID_73707588 | |
| 0.067 | 0.112 | 0.096 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.085 0.073 CID_15366337 0.096 0.058 CID_73707588 | CID_73707588 | |
| 0.099 | 0.143 | 0.262 | Anticoagulant | 0.262 0.036 CID_73707588 | CID_73707588 | |
| 0.024 | 0.068 | 0.071 | Estrogen agonist | 0.071 0.026 CID_15366337 | CID_15366337 | |
| 0.079 | 0.125 | 0.095 | Folate antagonist | 0.095 0.076 CID_15366337 0.09 0.088 CID_73707588 | CID_15366337 | |
| 0.017 | 0.062 | 0.03 | Complement C5a chemotactic receptor antagonist | 0.03 0.02 CID_15366337 | CID_15366337 | |
| 0.013 | 0.059 | 0.028 | Glucagon receptor antagonist | 0.028 0.023 CID_15366337 | CID_15366337 | |
| 0.075 | 0.125 | 0.123 | Alpha 2d adrenoreceptor antagonist | 0.123 0.021 CID_15366337 | CID_15366337 | |
| 0.027 | 0.078 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.032 CID_15366337 | CID_15366337 | |
| 0.079 | 0.131 | 0.144 | Tubulin antagonist | 0.144 0.061 CID_15366337 | CID_15366337 | |
| 0.016 | 0.068 | 0.025 | Vanilloid 2 agonist | 0.025 0.018 CID_73707588 | CID_73707588 | |
| 0.047 | 0.101 | 0.063 | Potassium channel (ATP-sensitive) blocker | 0.063 0.055 CID_15366337 | CID_15366337 | |
| 0.013 | 0.068 | 0.047 | Protein 30S ribosomal subunit inhibitor | 0.047 0.009 CID_73707588 | CID_73707588 | |
| 0.045 | 0.102 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 CID_73707588 | CID_73707588 | |
| 0.05 | 0.106 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.061 CID_15366337 | CID_15366337 | |
| 0.094 | 0.151 | 0.213 | Diuretic | 0.213 0.04 CID_73707588 | CID_73707588 | |
| 0.053 | 0.11 | 0.165 | Androgen antagonist | 0.165 0.019 CID_15366337 | CID_15366337 | |
| 0.013 | 0.07 | 0.034 | Glucocorticoid antagonist | 0.034 0.022 CID_15366337 | CID_15366337 | |
| 0.037 | 0.094 | 0.07 | Cyclin B1 inhibitor | 0.07 0.032 CID_15366337 | CID_15366337 | |
| 0.019 | 0.079 | 0.037 | Inosine monophosphate dehydrogenase inhibitor | 0.037 0.024 CID_15366337 | CID_15366337 | |
| 0.103 | 0.166 | 0.161 | Heat shock protein 90 alpha antagonist | 0.161 0.076 CID_15366337 | CID_15366337 | |
| 0.11 | 0.174 | 0.371 | Hepatoprotectant | 0.371 0.016 CID_73707588 | CID_73707588 | |
| 0.089 | 0.153 | 0.13 | Interleukin 1 antagonist | 0.13 0.075 CID_15366337 | CID_15366337 | |
| 0.036 | 0.101 | 0.066 | Fatty acid synthase inhibitor | 0.066 0.029 CID_15366337 | CID_15366337 | |
| 0.032 | 0.098 | 0.058 | Cyclin B inhibitor | 0.058 0.034 CID_15366337 | CID_15366337 | |
| 0.011 | 0.078 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.017 CID_73707588 | CID_73707588 | |
| 0.026 | 0.094 | 0.053 | Neuraminidase (Influenza A) inhibitor | 0.053 0.02 CID_73707588 | CID_73707588 | |
| 0.012 | 0.083 | 0.031 | HCV NS5B polymerase inhibitor | 0.031 0.022 CID_15366337 | CID_15366337 | |
| 0.012 | 0.083 | 0.078 | Progesterone antagonist | 0.078 0.011 CID_15366337 | CID_15366337 | |
| 0.135 | 0.208 | 0.568 | Hypoglycemic | 0.168 0.15 CID_15366337 0.568 0.01 CID_73707588 | CID_73707588 | |
| 0.075 | 0.151 | 0.142 | Alpha-N-acetylglucosaminidase inhibitor | 0.142 0.06 CID_15366337 0.14 0.061 CID_73707588 | CID_15366337 | |
| 0.113 | 0.194 | 0.221 | ATPase inhibitor | 0.164 0.079 CID_15366337 0.221 0.023 CID_73707588 | CID_73707588 | |
| 0.125 | 0.207 | 0.165 | Histone acetyltransferase inhibitor | 0.165 0.12 CID_15366337 | CID_15366337 | |
| 0.057 | 0.141 | 0.119 | Gastric antisecretory | 0.119 0.043 CID_15366337 | CID_15366337 | |
| 0.062 | 0.146 | 0.105 | Thioredoxin inhibitor | 0.086 0.069 CID_15366337 0.105 0.043 CID_73707588 | CID_73707588 | |
| 0.032 | 0.117 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.047 CID_15366337 | CID_15366337 | |
| 0.033 | 0.121 | 0.063 | Sphingosine 1-phosphate receptor 4 agonist | 0.063 0.051 CID_15366337 | CID_15366337 | |
| 0.013 | 0.101 | 0.065 | Nicotinic acid receptor agonist | 0.065 0.01 CID_15366337 | CID_15366337 | |
| 0.052 | 0.14 | 0.094 | 5-Lipoxygenase inhibitor | 0.094 0.068 CID_15366337 | CID_15366337 | |
| 0.037 | 0.127 | 0.072 | Benzodiazepine agonist | 0.072 0.048 CID_15366337 | CID_15366337 | |
| 0.021 | 0.112 | 0.037 | Liver X receptor alpha agonist | 0.037 0.035 CID_15366337 | CID_15366337 | |
| 0.028 | 0.123 | 0.063 | Aldosterone antagonist | 0.063 0.018 CID_15366337 | CID_15366337 | |
| 0.036 | 0.132 | 0.077 | Cyclin B3 inhibitor | 0.077 0.04 CID_15366337 | CID_15366337 | |
| 0.012 | 0.109 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.027 0.014 CID_15366337 0.044 0.006 CID_73707588 | CID_73707588 | |
| 0.054 | 0.152 | 0.192 | Expectorant | 0.192 0.022 CID_73707588 | CID_73707588 | |
| 0.073 | 0.171 | 0.11 | Alkaline phosphatase inhibitor | 0.11 0.1 CID_15366337 | CID_15366337 | |
| 0.096 | 0.194 | 0.141 | Dual specificity phosphatase inhibitor | 0.141 0.105 CID_15366337 | CID_15366337 | |
| 0.14 | 0.24 | 0.335 | Cholesterol antagonist | 0.255 0.122 CID_15366337 0.335 0.071 CID_73707588 | CID_73707588 | |
| 0.038 | 0.14 | 0.079 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.079 0.02 CID_15366337 | CID_15366337 | |
| 0.066 | 0.169 | 0.112 | Microtubule formation inhibitor | 0.112 0.071 CID_15366337 0.099 0.093 CID_73707588 | CID_15366337 | |
| 0.151 | 0.253 | 0.455 | Immunosuppressant | 0.21 0.186 CID_15366337 0.455 0.046 CID_73707588 | CID_73707588 | |
| 0.155 | 0.258 | 0.387 | Alpha-glucosidase inhibitor | 0.302 0.159 CID_15366337 0.387 0.121 CID_73707588 | CID_73707588 | |
| 0.03 | 0.133 | 0.076 | Glucose-6-phosphate translocase inhibitor | 0.076 0.013 CID_73707588 | CID_73707588 | |
| 0.04 | 0.145 | 0.054 | Leukotriene C antagonist | 0.054 0.046 CID_15366337 | CID_15366337 | |
| 0.009 | 0.115 | 0.046 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.018 CID_15366337 0.046 0.007 CID_73707588 | CID_73707588 | |
| 0.011 | 0.119 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 CID_15366337 | CID_15366337 | |
| 0.045 | 0.157 | 0.073 | Phosphodiesterase VI inhibitor | 0.073 0.055 CID_15366337 | CID_15366337 | |
| 0.019 | 0.132 | 0.051 | Glutamate (mGluR1) antagonist | 0.051 0.047 CID_15366337 | CID_15366337 | |
| 0.102 | 0.216 | 0.296 | Platelet antagonist | 0.296 0.054 CID_73707588 | CID_73707588 | |
| 0.034 | 0.149 | 0.067 | Polo-like kinase-2 inhibitor | 0.067 0.056 CID_15366337 | CID_15366337 | |
| 0.036 | 0.153 | 0.063 | Pregnane X receptor antagonist | 0.063 0.024 CID_15366337 | CID_15366337 | |
| 0.085 | 0.205 | 0.167 | DNA repair enzyme inhibitor | 0.167 0.019 CID_73707588 | CID_73707588 | |
| 0.01 | 0.129 | 0.028 | Nicotinic acid receptor 2 antagonist | 0.028 0.015 CID_15366337 | CID_15366337 | |
| 0.015 | 0.138 | 0.049 | Phosphorylase inhibitor | 0.049 0.031 CID_73707588 | CID_73707588 | |
| 0.03 | 0.155 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.046 CID_15366337 | CID_15366337 | |
| 0.097 | 0.224 | 0.239 | Non-steroidal antiinflammatory agent | 0.146 0.121 CID_15366337 0.239 0.047 CID_73707588 | CID_73707588 | |
| 0.036 | 0.167 | 0.073 | Histone deacetylase stimulant | 0.073 0.051 CID_73707588 | CID_73707588 | |
| 0.036 | 0.167 | 0.073 | Histone deacetylase SIRT1 stimulant | 0.073 0.051 CID_73707588 | CID_73707588 | |
| 0.029 | 0.161 | 0.072 | Neuraminidase (influenza) inhibitor | 0.072 0.033 CID_73707588 | CID_73707588 | |
| 0.081 | 0.213 | 0.184 | Hexokinase inhibitor | 0.145 0.085 CID_15366337 0.184 0.046 CID_73707588 | CID_73707588 | |
| 0.092 | 0.225 | 0.198 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.198 0.101 CID_15366337 | CID_15366337 | |
| 0.036 | 0.173 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.036 CID_73707588 | CID_73707588 | |
| 0.011 | 0.149 | 0.035 | Nicotinic acid receptor 2 agonist | 0.035 0.026 CID_15366337 | CID_15366337 | |
| 0.076 | 0.216 | 0.116 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.08 CID_15366337 | CID_15366337 | |
| 0.07 | 0.211 | 0.122 | Protein-tyrosine phosphatase inhibitor | 0.122 0.111 CID_15366337 | CID_15366337 | |
| 0.022 | 0.163 | 0.143 | Antineoplastic antibiotic | 0.143 0.032 CID_73707588 | CID_73707588 | |
| 0.03 | 0.172 | 0.055 | Dihydroorotate oxidase inhibitor | 0.055 0.038 CID_15366337 | CID_15366337 | |
| 0.016 | 0.163 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 CID_15366337 | CID_15366337 | |
| 0.055 | 0.205 | 0.094 | Multidrug resistance-associated protein 1 inhibitor | 0.094 0.09 CID_73707588 | CID_73707588 | |
| 0.081 | 0.232 | 0.352 | Platelet adhesion inhibitor | 0.352 0.019 CID_73707588 | CID_73707588 | |
| 0.037 | 0.189 | 0.091 | Protein-tyrosine phosphatase 1B inhibitor | 0.091 0.088 CID_15366337 | CID_15366337 | |
| 0.129 | 0.282 | 0.418 | Immunomodulator | 0.418 0.039 CID_73707588 | CID_73707588 | |
| 0.092 | 0.251 | 0.363 | Tumour necrosis factor alpha release inhibitor | 0.363 0.035 CID_73707588 | CID_73707588 | |
| 0.017 | 0.177 | 0.063 | Neuraminidase inhibitor | 0.063 0.04 CID_73707588 | CID_73707588 | |
| 0.042 | 0.218 | 0.088 | Uric acid excretion stimulant | 0.088 0.068 CID_73707588 | CID_73707588 | |
| 0.078 | 0.255 | 0.218 | Insulin secretagoues | 0.218 0.028 CID_73707588 | CID_73707588 | |
| 0.116 | 0.296 | 0.245 | Angiogenesis inhibitor | 0.245 0.127 CID_73707588 | CID_73707588 | |
| 0.024 | 0.206 | 0.084 | Heparanase inhibitor | 0.084 0.005 CID_73707588 | CID_73707588 | |
| 0.015 | 0.207 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 CID_73707588 | CID_73707588 | |
| 0.02 | 0.221 | 0.052 | Potassium channel Kv1.5 blocker | 0.052 0.046 CID_15366337 | CID_15366337 | |
| 0.023 | 0.227 | 0.078 | Factor IXa inhibitor | 0.078 0.017 CID_73707588 | CID_73707588 | |
| 0.035 | 0.239 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | 0.066 0.065 CID_15366337 | CID_15366337 | |
| 0.061 | 0.283 | 0.15 | Farnesoid X receptor antagonist | 0.15 0.052 CID_15366337 | CID_15366337 | |
| 0.015 | 0.25 | 0.088 | Protein 50S ribosomal subunit inhibitor | 0.088 0.017 CID_73707588 | CID_73707588 | |
| 0.045 | 0.289 | 0.117 | Transcription factor NF kappa B stimulant | 0.117 0.027 CID_73707588 | CID_73707588 | |
| 0.031 | 0.281 | 0.109 | ATPase (Vacuolar H+) inhibitor | 0.109 0.029 CID_73707588 | CID_73707588 | |
| 0.05 | 0.318 | 0.083 | T cell inhibitor | 0.083 0.055 CID_73707588 | CID_73707588 | |
| 0.014 | 0.312 | 0.079 | HIV-1 reverse transcriptase inhibitor | 0.079 0.043 CID_15366337 | CID_15366337 | |
| 0.086 | 0.454 | 0.131 | CC chemokine 6 receptor antagonist | 0.131 0.067 CID_73707588 | CID_73707588 | |
| 0.112 | 0.496 | 0.651 | Antiinflammatory | 0.651 0.04 CID_73707588 | CID_73707588 | |
| 0.081 | 0.531 | 0.665 | Cyclophilin D inhibitor | 0.665 0.018 CID_73707588 | CID_73707588 | |
| 0.021 | 0.585 | 0.165 | Cell adhesion inhibitor | 0.165 0.038 CID_73707588 | CID_73707588 | |
| 0.01 | 0.623 | 0.077 | Cell adhesion molecule inhibitor | 0.077 0.058 CID_73707588 | CID_73707588 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |